Modular Medical 通过行使认股权证筹集了 $4.4M，推进其胰岛素贴片泵获得 FDA 批准。 Modular Medical raised $4.4M by exercising warrants, advancing its insulin patch pump toward FDA approval.

Modular Medical(MODD)通过执行650万张罚单,每股68美元,筹集了440万美元的总收益,该公司发出新的未登记罚单,额外330万张,每股84美元。 Modular Medical (MODD) raised $4.4 million in gross proceeds by exercising 6.5 million warrants at $0.68 per share, with the company issuing new unregistered warrants for 3.3 million additional shares at $0.84 each. 收益将支持周转资本和一般公司需求。 Proceeds will support working capital and general corporate needs. 新的逮捕证是私人安插免登记的一部分,有效期为五年。 The new warrants, part of a private placement exempt from registration, are valid for five years. 公司正在开发一种价格实惠的胰岛素补丁, The company, developing an affordable insulin patch pump, is advancing toward FDA clearance and commercial launch. Newbridge证券公司为这一交易提供了便利。 The transaction was facilitated by Newbridge Securities Corporation.